Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 100 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 6410747

    Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 25, 2002 · Expires Jun 20, 2022

    expired
  2. US 6407080

    N-(pyrimidinyl)-aspartic acid analogs as interleukin-1&bgr; converting enzyme inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 18, 2002 · Expires Jun 13, 2022

    expired
  3. US 6399774

    Compounds having activity as inhibitors of cytochrome P450RAI

    ALLERGAN SALES INC [US] · Granted Jun 4, 2002 · Expires May 30, 2022

    expired
  4. US 6399633

    Use of 4-H-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation

    The Board of Regents of the University of Texas System · Granted Jun 4, 2002 · Expires May 30, 2022

    expired
  5. US 6399627

    Inhibitors of factor Xa

    COR Therapeutics, Inc. · Granted Jun 4, 2002 · Expires May 30, 2022

    expired
  6. US 6395763

    Prodrugs of carbamate inhibitors of IMPDH

    Vertex Pharmaceuticals Incorporated · Granted May 28, 2002 · Expires May 23, 2022

    expired
  7. US 6391909

    Anandamide inhibitors as analgesic agents

    UNIVERSITY OF CONNECTICUT · Granted May 21, 2002 · Expires May 16, 2022

    expired
  8. US 6392046

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted May 21, 2002 · Expires May 16, 2022

    expired
  9. US 6387923

    Imminoribitol PNP inhibitors, preparation thereof and use thereof

    BioCryst Pharmaceuticals, Inc. · Granted May 14, 2002 · Expires May 9, 2022

    expired
  10. US 6383790

    High affinity protein kinase inhibitors

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted May 7, 2002 · Expires May 2, 2022

    expired
  11. US 6376467

    Use of inhibitors of protein kinase C epsilon to treat pain

    The Regents of the University of California · Granted Apr 23, 2002 · Expires Apr 18, 2022

    expired
  12. US 6376515

    Benzamides and related inhibitors of factor Xa

    COR Therapeutics, Inc. · Granted Apr 23, 2002 · Expires Apr 18, 2022

    expired
  13. US 6372778

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Apr 16, 2002 · Expires Apr 11, 2022

    expired
  14. US 6369080

    Selective factor Xa inhibitors

    COR Therapeutics, Inc. · Granted Apr 9, 2002 · Expires Apr 4, 2022

    expired
  15. US 6369063

    Selective factor Xa inhibitors

    COR Therapeutics, Inc. · Granted Apr 9, 2002 · Expires Apr 4, 2022

    expired
  16. US 6365359

    Inhibitors of prion formation

    The Regents of the University of California · Granted Apr 2, 2002 · Expires Mar 28, 2022

    expired
  17. US 6355619

    Peptide tumor cell growth inhibitors

    The Board of Regents of the University of Texas System · Granted Mar 12, 2002 · Expires Mar 7, 2022

    expired
  18. US 6355610

    Inhibitors of formation of protease resistant prion protein

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 12, 2002 · Expires Mar 7, 2022

    expired
  19. US 6353097

    Nucleic acids encoding signal transduction inhibitors of allergic reactions

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 5, 2002 · Expires Feb 28, 2022

    expired
  20. US 6350785

    Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors

    Maxim Pharmaceuticals, Inc. · Granted Feb 26, 2002 · Expires Feb 21, 2022

    expired
  21. US 6350741

    Inhibitors of interleukin-1&bgr; converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Feb 26, 2002 · Expires Feb 21, 2022

    expired
  22. US 6344465

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2002 · Expires Jan 31, 2022

    expired
  23. US 6333321

    Selective factor Xa inhibitors

    COR Therapeutics, Inc. · Granted Dec 25, 2001 · Expires Dec 20, 2021

    expired
  24. US 6333033

    Autoantibody inhibitors

    The Regents of the University of California · Granted Dec 25, 2001 · Expires Dec 20, 2021

    expired